nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—HSP90AA1—hematologic cancer	0.465	1	CbGaD
Rifabutin—CYP1A2—Anagrelide—hematologic cancer	0.0302	0.111	CbGbCtD
Rifabutin—CYP1A2—Carmustine—hematologic cancer	0.0158	0.0585	CbGbCtD
Rifabutin—CYP1A2—Methoxsalen—hematologic cancer	0.0135	0.0497	CbGbCtD
Rifabutin—CYP1A2—Bortezomib—hematologic cancer	0.0128	0.0473	CbGbCtD
Rifabutin—CYP1A2—Daunorubicin—hematologic cancer	0.0123	0.0452	CbGbCtD
Rifabutin—CYP1A2—Alitretinoin—hematologic cancer	0.012	0.0443	CbGbCtD
Rifabutin—CYP1A2—Thalidomide—hematologic cancer	0.0112	0.0412	CbGbCtD
Rifabutin—CYP3A4—Bexarotene—hematologic cancer	0.011	0.0404	CbGbCtD
Rifabutin—CYP3A4—Lomustine—hematologic cancer	0.0102	0.0376	CbGbCtD
Rifabutin—CYP3A4—Busulfan—hematologic cancer	0.0102	0.0376	CbGbCtD
Rifabutin—CYP1A2—Dacarbazine—hematologic cancer	0.0096	0.0354	CbGbCtD
Rifabutin—CYP1A2—Imatinib—hematologic cancer	0.00939	0.0346	CbGbCtD
Rifabutin—CYP3A4—Thiotepa—hematologic cancer	0.00907	0.0335	CbGbCtD
Rifabutin—CYP1A2—Dasatinib—hematologic cancer	0.00754	0.0278	CbGbCtD
Rifabutin—CYP3A4—Methoxsalen—hematologic cancer	0.00706	0.026	CbGbCtD
Rifabutin—CYP3A4—Bortezomib—hematologic cancer	0.00671	0.0248	CbGbCtD
Rifabutin—CYP3A4—Daunorubicin—hematologic cancer	0.00642	0.0237	CbGbCtD
Rifabutin—CYP3A4—Cytarabine—hematologic cancer	0.00566	0.0209	CbGbCtD
Rifabutin—CYP3A4—Teniposide—hematologic cancer	0.00558	0.0206	CbGbCtD
Rifabutin—CYP3A4—Ifosfamide—hematologic cancer	0.00515	0.019	CbGbCtD
Rifabutin—CYP3A4—Imatinib—hematologic cancer	0.00492	0.0181	CbGbCtD
Rifabutin—CYP1A2—Etoposide—hematologic cancer	0.0047	0.0173	CbGbCtD
Rifabutin—CYP3A4—Ruxolitinib—hematologic cancer	0.00463	0.0171	CbGbCtD
Rifabutin—CYP3A4—Nilotinib—hematologic cancer	0.00447	0.0165	CbGbCtD
Rifabutin—CYP3A4—Vinorelbine—hematologic cancer	0.00443	0.0164	CbGbCtD
Rifabutin—CYP3A4—Triamcinolone—hematologic cancer	0.00405	0.015	CbGbCtD
Rifabutin—CYP3A4—Dasatinib—hematologic cancer	0.00395	0.0146	CbGbCtD
Rifabutin—CYP3A4—Mitoxantrone—hematologic cancer	0.0039	0.0144	CbGbCtD
Rifabutin—CYP3A4—Betamethasone—hematologic cancer	0.00348	0.0128	CbGbCtD
Rifabutin—CYP3A4—Prednisolone—hematologic cancer	0.00343	0.0127	CbGbCtD
Rifabutin—HSP90B1—hematopoietic system—hematologic cancer	0.00327	0.114	CbGeAlD
Rifabutin—CYP3A4—Prednisone—hematologic cancer	0.00324	0.012	CbGbCtD
Rifabutin—CYP3A4—Irinotecan—hematologic cancer	0.00307	0.0113	CbGbCtD
Rifabutin—CYP3A4—Vinblastine—hematologic cancer	0.00273	0.0101	CbGbCtD
Rifabutin—CYP3A4—Vincristine—hematologic cancer	0.00268	0.00991	CbGbCtD
Rifabutin—HSP90B1—gonad—hematologic cancer	0.00249	0.0868	CbGeAlD
Rifabutin—CYP3A4—Etoposide—hematologic cancer	0.00246	0.00908	CbGbCtD
Rifabutin—HSP90AA1—hematopoietic system—hematologic cancer	0.00239	0.0835	CbGeAlD
Rifabutin—HSP90B1—blood—hematologic cancer	0.00217	0.0756	CbGeAlD
Rifabutin—HSP90B1—bone marrow—hematologic cancer	0.0021	0.0732	CbGeAlD
Rifabutin—CYP3A4—Dexamethasone—hematologic cancer	0.00202	0.00746	CbGbCtD
Rifabutin—HSP90B1—lung—hematologic cancer	0.0019	0.0663	CbGeAlD
Rifabutin—HSP90AA1—gonad—hematologic cancer	0.00182	0.0635	CbGeAlD
Rifabutin—HSP90B1—testis—hematologic cancer	0.00179	0.0625	CbGeAlD
Rifabutin—CYP3A4—Doxorubicin—hematologic cancer	0.00168	0.00619	CbGbCtD
Rifabutin—HSP90AA1—blood—hematologic cancer	0.00158	0.0553	CbGeAlD
Rifabutin—HSP90AA1—bone marrow—hematologic cancer	0.00153	0.0535	CbGeAlD
Rifabutin—HSP90AA1—lung—hematologic cancer	0.00139	0.0485	CbGeAlD
Rifabutin—HSP90AA1—Gemcitabine—Cytarabine—hematologic cancer	0.00133	1	CbGdCrCtD
Rifabutin—HSP90AA1—testis—hematologic cancer	0.00131	0.0457	CbGeAlD
Rifabutin—HSP90B1—lymph node—hematologic cancer	0.0013	0.0453	CbGeAlD
Rifabutin—HSP90AA1—lymph node—hematologic cancer	0.00095	0.0332	CbGeAlD
Rifabutin—CYP1A2—hematopoietic system—hematologic cancer	0.000773	0.027	CbGeAlD
Rifabutin—Rifampicin—ABCC3—hematologic cancer	0.000676	0.484	CrCbGaD
Rifabutin—Rifampicin—UGT1A1—hematologic cancer	0.000584	0.418	CrCbGaD
Rifabutin—CYP3A4—hematopoietic system—hematologic cancer	0.00056	0.0195	CbGeAlD
Rifabutin—CYP1A2—blood—hematologic cancer	0.000512	0.0179	CbGeAlD
Rifabutin—CYP1A2—lung—hematologic cancer	0.000449	0.0157	CbGeAlD
Rifabutin—CYP3A4—blood—hematologic cancer	0.000371	0.0129	CbGeAlD
Rifabutin—Rifampicin—ABCB1—hematologic cancer	0.000137	0.0978	CrCbGaD
Rifabutin—Dyspnoea—Triamcinolone—hematologic cancer	2.91e-05	0.000223	CcSEcCtD
Rifabutin—Rash—Alitretinoin—hematologic cancer	2.91e-05	0.000223	CcSEcCtD
Rifabutin—Dermatitis—Alitretinoin—hematologic cancer	2.91e-05	0.000223	CcSEcCtD
Rifabutin—Thrombocytopenia—Betamethasone—hematologic cancer	2.9e-05	0.000222	CcSEcCtD
Rifabutin—Thrombocytopenia—Dexamethasone—hematologic cancer	2.9e-05	0.000222	CcSEcCtD
Rifabutin—Vomiting—Ifosfamide—hematologic cancer	2.9e-05	0.000222	CcSEcCtD
Rifabutin—Hypersensitivity—Cisplatin—hematologic cancer	2.9e-05	0.000222	CcSEcCtD
Rifabutin—Headache—Alitretinoin—hematologic cancer	2.89e-05	0.000222	CcSEcCtD
Rifabutin—Diarrhoea—Gemcitabine—hematologic cancer	2.89e-05	0.000221	CcSEcCtD
Rifabutin—Nausea—Thalidomide—hematologic cancer	2.88e-05	0.000221	CcSEcCtD
Rifabutin—Dyspepsia—Triamcinolone—hematologic cancer	2.88e-05	0.00022	CcSEcCtD
Rifabutin—Rash—Ifosfamide—hematologic cancer	2.88e-05	0.00022	CcSEcCtD
Rifabutin—Dermatitis—Ifosfamide—hematologic cancer	2.87e-05	0.00022	CcSEcCtD
Rifabutin—Jaundice—Doxorubicin—hematologic cancer	2.86e-05	0.000219	CcSEcCtD
Rifabutin—Abdominal pain—Etoposide—hematologic cancer	2.85e-05	0.000218	CcSEcCtD
Rifabutin—Body temperature increased—Etoposide—hematologic cancer	2.85e-05	0.000218	CcSEcCtD
Rifabutin—Hepatitis—Epirubicin—hematologic cancer	2.84e-05	0.000218	CcSEcCtD
Rifabutin—Eye disorder—Methotrexate—hematologic cancer	2.84e-05	0.000217	CcSEcCtD
Rifabutin—Vomiting—Vincristine—hematologic cancer	2.83e-05	0.000217	CcSEcCtD
Rifabutin—Anorexia—Betamethasone—hematologic cancer	2.83e-05	0.000217	CcSEcCtD
Rifabutin—Anorexia—Dexamethasone—hematologic cancer	2.83e-05	0.000217	CcSEcCtD
Rifabutin—Asthenia—Cisplatin—hematologic cancer	2.82e-05	0.000216	CcSEcCtD
Rifabutin—Rash—Vincristine—hematologic cancer	2.81e-05	0.000215	CcSEcCtD
Rifabutin—Dermatitis—Vincristine—hematologic cancer	2.8e-05	0.000215	CcSEcCtD
Rifabutin—Pain—Triamcinolone—hematologic cancer	2.8e-05	0.000214	CcSEcCtD
Rifabutin—Connective tissue disorder—Epirubicin—hematologic cancer	2.79e-05	0.000214	CcSEcCtD
Rifabutin—Headache—Vincristine—hematologic cancer	2.79e-05	0.000213	CcSEcCtD
Rifabutin—Hepatobiliary disease—Doxorubicin—hematologic cancer	2.77e-05	0.000212	CcSEcCtD
Rifabutin—Nausea—Carmustine—hematologic cancer	2.77e-05	0.000212	CcSEcCtD
Rifabutin—Vomiting—Irinotecan—hematologic cancer	2.76e-05	0.000211	CcSEcCtD
Rifabutin—Vomiting—Mitoxantrone—hematologic cancer	2.76e-05	0.000211	CcSEcCtD
Rifabutin—Immune system disorder—Methotrexate—hematologic cancer	2.74e-05	0.00021	CcSEcCtD
Rifabutin—Nausea—Alitretinoin—hematologic cancer	2.74e-05	0.00021	CcSEcCtD
Rifabutin—Convulsion—Prednisone—hematologic cancer	2.74e-05	0.00021	CcSEcCtD
Rifabutin—Agranulocytosis—Doxorubicin—hematologic cancer	2.74e-05	0.000209	CcSEcCtD
Rifabutin—Rash—Irinotecan—hematologic cancer	2.73e-05	0.000209	CcSEcCtD
Rifabutin—Rash—Mitoxantrone—hematologic cancer	2.73e-05	0.000209	CcSEcCtD
Rifabutin—Dermatitis—Mitoxantrone—hematologic cancer	2.73e-05	0.000209	CcSEcCtD
Rifabutin—Dermatitis—Irinotecan—hematologic cancer	2.73e-05	0.000209	CcSEcCtD
Rifabutin—Headache—Mitoxantrone—hematologic cancer	2.71e-05	0.000208	CcSEcCtD
Rifabutin—Headache—Irinotecan—hematologic cancer	2.71e-05	0.000208	CcSEcCtD
Rifabutin—Nausea—Ifosfamide—hematologic cancer	2.71e-05	0.000208	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.7e-05	0.000207	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.7e-05	0.000207	CcSEcCtD
Rifabutin—Arthralgia—Prednisone—hematologic cancer	2.69e-05	0.000206	CcSEcCtD
Rifabutin—Myalgia—Prednisone—hematologic cancer	2.69e-05	0.000206	CcSEcCtD
Rifabutin—Feeling abnormal—Triamcinolone—hematologic cancer	2.69e-05	0.000206	CcSEcCtD
Rifabutin—Diarrhoea—Cisplatin—hematologic cancer	2.69e-05	0.000206	CcSEcCtD
Rifabutin—Vomiting—Gemcitabine—hematologic cancer	2.68e-05	0.000206	CcSEcCtD
Rifabutin—Insomnia—Dexamethasone—hematologic cancer	2.68e-05	0.000205	CcSEcCtD
Rifabutin—Insomnia—Betamethasone—hematologic cancer	2.68e-05	0.000205	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.68e-05	0.000205	CcSEcCtD
Rifabutin—Paraesthesia—Betamethasone—hematologic cancer	2.66e-05	0.000204	CcSEcCtD
Rifabutin—Paraesthesia—Dexamethasone—hematologic cancer	2.66e-05	0.000204	CcSEcCtD
Rifabutin—Rash—Gemcitabine—hematologic cancer	2.66e-05	0.000204	CcSEcCtD
Rifabutin—Dermatitis—Gemcitabine—hematologic cancer	2.66e-05	0.000204	CcSEcCtD
Rifabutin—Eye disorder—Epirubicin—hematologic cancer	2.66e-05	0.000204	CcSEcCtD
Rifabutin—Hypersensitivity—Etoposide—hematologic cancer	2.66e-05	0.000203	CcSEcCtD
Rifabutin—Headache—Gemcitabine—hematologic cancer	2.64e-05	0.000202	CcSEcCtD
Rifabutin—Nausea—Vincristine—hematologic cancer	2.64e-05	0.000202	CcSEcCtD
Rifabutin—Hepatitis—Doxorubicin—hematologic cancer	2.63e-05	0.000201	CcSEcCtD
Rifabutin—Hypersensitivity—Prednisolone—hematologic cancer	2.62e-05	0.000201	CcSEcCtD
Rifabutin—Dyspepsia—Betamethasone—hematologic cancer	2.61e-05	0.0002	CcSEcCtD
Rifabutin—Dyspepsia—Dexamethasone—hematologic cancer	2.61e-05	0.0002	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—hematologic cancer	2.59e-05	0.000198	CcSEcCtD
Rifabutin—Asthenia—Etoposide—hematologic cancer	2.59e-05	0.000198	CcSEcCtD
Rifabutin—Connective tissue disorder—Doxorubicin—hematologic cancer	2.59e-05	0.000198	CcSEcCtD
Rifabutin—Body temperature increased—Triamcinolone—hematologic cancer	2.58e-05	0.000198	CcSEcCtD
Rifabutin—Decreased appetite—Betamethasone—hematologic cancer	2.58e-05	0.000197	CcSEcCtD
Rifabutin—Decreased appetite—Dexamethasone—hematologic cancer	2.58e-05	0.000197	CcSEcCtD
Rifabutin—Nausea—Mitoxantrone—hematologic cancer	2.57e-05	0.000197	CcSEcCtD
Rifabutin—Nausea—Irinotecan—hematologic cancer	2.57e-05	0.000197	CcSEcCtD
Rifabutin—Immune system disorder—Epirubicin—hematologic cancer	2.57e-05	0.000197	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.56e-05	0.000196	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.56e-05	0.000196	CcSEcCtD
Rifabutin—Pruritus—Etoposide—hematologic cancer	2.55e-05	0.000195	CcSEcCtD
Rifabutin—Shock—Prednisone—hematologic cancer	2.54e-05	0.000195	CcSEcCtD
Rifabutin—Pain—Dexamethasone—hematologic cancer	2.54e-05	0.000194	CcSEcCtD
Rifabutin—Pain—Betamethasone—hematologic cancer	2.54e-05	0.000194	CcSEcCtD
Rifabutin—Skin disorder—Prednisone—hematologic cancer	2.51e-05	0.000192	CcSEcCtD
Rifabutin—Nausea—Gemcitabine—hematologic cancer	2.51e-05	0.000192	CcSEcCtD
Rifabutin—Vomiting—Cisplatin—hematologic cancer	2.5e-05	0.000192	CcSEcCtD
Rifabutin—Rash—Cisplatin—hematologic cancer	2.48e-05	0.00019	CcSEcCtD
Rifabutin—Dermatitis—Cisplatin—hematologic cancer	2.48e-05	0.00019	CcSEcCtD
Rifabutin—Diarrhoea—Etoposide—hematologic cancer	2.47e-05	0.000189	CcSEcCtD
Rifabutin—Anorexia—Prednisone—hematologic cancer	2.46e-05	0.000189	CcSEcCtD
Rifabutin—Eye disorder—Doxorubicin—hematologic cancer	2.46e-05	0.000188	CcSEcCtD
Rifabutin—Anaemia—Methotrexate—hematologic cancer	2.44e-05	0.000187	CcSEcCtD
Rifabutin—Feeling abnormal—Betamethasone—hematologic cancer	2.44e-05	0.000187	CcSEcCtD
Rifabutin—Feeling abnormal—Dexamethasone—hematologic cancer	2.44e-05	0.000187	CcSEcCtD
Rifabutin—Flatulence—Epirubicin—hematologic cancer	2.44e-05	0.000187	CcSEcCtD
Rifabutin—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.43e-05	0.000186	CcSEcCtD
Rifabutin—Gastrointestinal pain—Betamethasone—hematologic cancer	2.43e-05	0.000186	CcSEcCtD
Rifabutin—Dysgeusia—Epirubicin—hematologic cancer	2.42e-05	0.000186	CcSEcCtD
Rifabutin—Hypersensitivity—Triamcinolone—hematologic cancer	2.41e-05	0.000184	CcSEcCtD
Rifabutin—Immune system disorder—Doxorubicin—hematologic cancer	2.38e-05	0.000182	CcSEcCtD
Rifabutin—Leukopenia—Methotrexate—hematologic cancer	2.37e-05	0.000181	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.35e-05	0.00018	CcSEcCtD
Rifabutin—Asthenia—Triamcinolone—hematologic cancer	2.35e-05	0.00018	CcSEcCtD
Rifabutin—Abdominal pain—Betamethasone—hematologic cancer	2.34e-05	0.00018	CcSEcCtD
Rifabutin—Body temperature increased—Betamethasone—hematologic cancer	2.34e-05	0.00018	CcSEcCtD
Rifabutin—Body temperature increased—Dexamethasone—hematologic cancer	2.34e-05	0.00018	CcSEcCtD
Rifabutin—Abdominal pain—Dexamethasone—hematologic cancer	2.34e-05	0.00018	CcSEcCtD
Rifabutin—Nausea—Cisplatin—hematologic cancer	2.34e-05	0.000179	CcSEcCtD
Rifabutin—Insomnia—Prednisone—hematologic cancer	2.34e-05	0.000179	CcSEcCtD
Rifabutin—Paraesthesia—Prednisone—hematologic cancer	2.32e-05	0.000178	CcSEcCtD
Rifabutin—Pruritus—Triamcinolone—hematologic cancer	2.31e-05	0.000177	CcSEcCtD
Rifabutin—Convulsion—Methotrexate—hematologic cancer	2.29e-05	0.000176	CcSEcCtD
Rifabutin—Vomiting—Etoposide—hematologic cancer	2.29e-05	0.000175	CcSEcCtD
Rifabutin—Anaemia—Epirubicin—hematologic cancer	2.29e-05	0.000175	CcSEcCtD
Rifabutin—Dyspepsia—Prednisone—hematologic cancer	2.27e-05	0.000174	CcSEcCtD
Rifabutin—Rash—Etoposide—hematologic cancer	2.27e-05	0.000174	CcSEcCtD
Rifabutin—Dermatitis—Etoposide—hematologic cancer	2.27e-05	0.000174	CcSEcCtD
Rifabutin—Headache—Etoposide—hematologic cancer	2.26e-05	0.000173	CcSEcCtD
Rifabutin—Flatulence—Doxorubicin—hematologic cancer	2.26e-05	0.000173	CcSEcCtD
Rifabutin—Myalgia—Methotrexate—hematologic cancer	2.25e-05	0.000172	CcSEcCtD
Rifabutin—Chest pain—Methotrexate—hematologic cancer	2.25e-05	0.000172	CcSEcCtD
Rifabutin—Arthralgia—Methotrexate—hematologic cancer	2.25e-05	0.000172	CcSEcCtD
Rifabutin—Decreased appetite—Prednisone—hematologic cancer	2.25e-05	0.000172	CcSEcCtD
Rifabutin—Dysgeusia—Doxorubicin—hematologic cancer	2.24e-05	0.000172	CcSEcCtD
Rifabutin—Rash—Prednisolone—hematologic cancer	2.24e-05	0.000172	CcSEcCtD
Rifabutin—Dermatitis—Prednisolone—hematologic cancer	2.24e-05	0.000171	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.24e-05	0.000171	CcSEcCtD
Rifabutin—Headache—Prednisolone—hematologic cancer	2.23e-05	0.000171	CcSEcCtD
Rifabutin—Leukopenia—Epirubicin—hematologic cancer	2.22e-05	0.00017	CcSEcCtD
Rifabutin—Confusional state—Methotrexate—hematologic cancer	2.18e-05	0.000167	CcSEcCtD
Rifabutin—Convulsion—Epirubicin—hematologic cancer	2.14e-05	0.000164	CcSEcCtD
Rifabutin—Nausea—Etoposide—hematologic cancer	2.14e-05	0.000164	CcSEcCtD
Rifabutin—Feeling abnormal—Prednisone—hematologic cancer	2.13e-05	0.000163	CcSEcCtD
Rifabutin—Asthenia—Dexamethasone—hematologic cancer	2.13e-05	0.000163	CcSEcCtD
Rifabutin—Asthenia—Betamethasone—hematologic cancer	2.13e-05	0.000163	CcSEcCtD
Rifabutin—Anaemia—Doxorubicin—hematologic cancer	2.12e-05	0.000162	CcSEcCtD
Rifabutin—Thrombocytopenia—Methotrexate—hematologic cancer	2.11e-05	0.000162	CcSEcCtD
Rifabutin—Gastrointestinal pain—Prednisone—hematologic cancer	2.11e-05	0.000162	CcSEcCtD
Rifabutin—Nausea—Prednisolone—hematologic cancer	2.11e-05	0.000162	CcSEcCtD
Rifabutin—Myalgia—Epirubicin—hematologic cancer	2.11e-05	0.000161	CcSEcCtD
Rifabutin—Arthralgia—Epirubicin—hematologic cancer	2.11e-05	0.000161	CcSEcCtD
Rifabutin—Chest pain—Epirubicin—hematologic cancer	2.11e-05	0.000161	CcSEcCtD
Rifabutin—Pruritus—Dexamethasone—hematologic cancer	2.1e-05	0.000161	CcSEcCtD
Rifabutin—Pruritus—Betamethasone—hematologic cancer	2.1e-05	0.000161	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—hematologic cancer	2.1e-05	0.000161	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.09e-05	0.00016	CcSEcCtD
Rifabutin—Vomiting—Triamcinolone—hematologic cancer	2.08e-05	0.000159	CcSEcCtD
Rifabutin—Rash—Triamcinolone—hematologic cancer	2.06e-05	0.000158	CcSEcCtD
Rifabutin—Dermatitis—Triamcinolone—hematologic cancer	2.06e-05	0.000158	CcSEcCtD
Rifabutin—Anorexia—Methotrexate—hematologic cancer	2.06e-05	0.000158	CcSEcCtD
Rifabutin—Leukopenia—Doxorubicin—hematologic cancer	2.05e-05	0.000157	CcSEcCtD
Rifabutin—Headache—Triamcinolone—hematologic cancer	2.05e-05	0.000157	CcSEcCtD
Rifabutin—Body temperature increased—Prednisone—hematologic cancer	2.04e-05	0.000156	CcSEcCtD
Rifabutin—Abdominal pain—Prednisone—hematologic cancer	2.04e-05	0.000156	CcSEcCtD
Rifabutin—Confusional state—Epirubicin—hematologic cancer	2.04e-05	0.000156	CcSEcCtD
Rifabutin—Diarrhoea—Dexamethasone—hematologic cancer	2.03e-05	0.000155	CcSEcCtD
Rifabutin—Diarrhoea—Betamethasone—hematologic cancer	2.03e-05	0.000155	CcSEcCtD
Rifabutin—Shock—Epirubicin—hematologic cancer	1.99e-05	0.000152	CcSEcCtD
Rifabutin—Convulsion—Doxorubicin—hematologic cancer	1.98e-05	0.000152	CcSEcCtD
Rifabutin—Thrombocytopenia—Epirubicin—hematologic cancer	1.98e-05	0.000151	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.97e-05	0.000151	CcSEcCtD
Rifabutin—Skin disorder—Epirubicin—hematologic cancer	1.96e-05	0.00015	CcSEcCtD
Rifabutin—Insomnia—Methotrexate—hematologic cancer	1.95e-05	0.00015	CcSEcCtD
Rifabutin—Arthralgia—Doxorubicin—hematologic cancer	1.95e-05	0.000149	CcSEcCtD
Rifabutin—Myalgia—Doxorubicin—hematologic cancer	1.95e-05	0.000149	CcSEcCtD
Rifabutin—Chest pain—Doxorubicin—hematologic cancer	1.95e-05	0.000149	CcSEcCtD
Rifabutin—Nausea—Triamcinolone—hematologic cancer	1.94e-05	0.000149	CcSEcCtD
Rifabutin—Paraesthesia—Methotrexate—hematologic cancer	1.94e-05	0.000148	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.94e-05	0.000148	CcSEcCtD
Rifabutin—Anorexia—Epirubicin—hematologic cancer	1.93e-05	0.000147	CcSEcCtD
Rifabutin—Dyspnoea—Methotrexate—hematologic cancer	1.92e-05	0.000147	CcSEcCtD
Rifabutin—Hypersensitivity—Prednisone—hematologic cancer	1.9e-05	0.000146	CcSEcCtD
Rifabutin—Dyspepsia—Methotrexate—hematologic cancer	1.9e-05	0.000146	CcSEcCtD
Rifabutin—Vomiting—Betamethasone—hematologic cancer	1.89e-05	0.000144	CcSEcCtD
Rifabutin—Vomiting—Dexamethasone—hematologic cancer	1.89e-05	0.000144	CcSEcCtD
Rifabutin—Confusional state—Doxorubicin—hematologic cancer	1.88e-05	0.000144	CcSEcCtD
Rifabutin—Decreased appetite—Methotrexate—hematologic cancer	1.88e-05	0.000144	CcSEcCtD
Rifabutin—Rash—Betamethasone—hematologic cancer	1.87e-05	0.000143	CcSEcCtD
Rifabutin—Rash—Dexamethasone—hematologic cancer	1.87e-05	0.000143	CcSEcCtD
Rifabutin—Dermatitis—Betamethasone—hematologic cancer	1.87e-05	0.000143	CcSEcCtD
Rifabutin—Dermatitis—Dexamethasone—hematologic cancer	1.87e-05	0.000143	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.86e-05	0.000143	CcSEcCtD
Rifabutin—Headache—Betamethasone—hematologic cancer	1.86e-05	0.000142	CcSEcCtD
Rifabutin—Headache—Dexamethasone—hematologic cancer	1.86e-05	0.000142	CcSEcCtD
Rifabutin—Asthenia—Prednisone—hematologic cancer	1.85e-05	0.000142	CcSEcCtD
Rifabutin—Pain—Methotrexate—hematologic cancer	1.85e-05	0.000141	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.84e-05	0.000141	CcSEcCtD
Rifabutin—Shock—Doxorubicin—hematologic cancer	1.84e-05	0.000141	CcSEcCtD
Rifabutin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.83e-05	0.00014	CcSEcCtD
Rifabutin—Pruritus—Prednisone—hematologic cancer	1.83e-05	0.00014	CcSEcCtD
Rifabutin—Insomnia—Epirubicin—hematologic cancer	1.83e-05	0.00014	CcSEcCtD
Rifabutin—Skin disorder—Doxorubicin—hematologic cancer	1.82e-05	0.000139	CcSEcCtD
Rifabutin—Paraesthesia—Epirubicin—hematologic cancer	1.81e-05	0.000139	CcSEcCtD
Rifabutin—Dyspnoea—Epirubicin—hematologic cancer	1.8e-05	0.000138	CcSEcCtD
Rifabutin—Anorexia—Doxorubicin—hematologic cancer	1.78e-05	0.000136	CcSEcCtD
Rifabutin—Feeling abnormal—Methotrexate—hematologic cancer	1.78e-05	0.000136	CcSEcCtD
Rifabutin—Dyspepsia—Epirubicin—hematologic cancer	1.78e-05	0.000136	CcSEcCtD
Rifabutin—Diarrhoea—Prednisone—hematologic cancer	1.77e-05	0.000135	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.77e-05	0.000135	CcSEcCtD
Rifabutin—Nausea—Dexamethasone—hematologic cancer	1.76e-05	0.000135	CcSEcCtD
Rifabutin—Nausea—Betamethasone—hematologic cancer	1.76e-05	0.000135	CcSEcCtD
Rifabutin—Decreased appetite—Epirubicin—hematologic cancer	1.76e-05	0.000134	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.74e-05	0.000134	CcSEcCtD
Rifabutin—Pain—Epirubicin—hematologic cancer	1.73e-05	0.000132	CcSEcCtD
Rifabutin—Body temperature increased—Methotrexate—hematologic cancer	1.71e-05	0.000131	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—hematologic cancer	1.71e-05	0.000131	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.7e-05	0.00013	CcSEcCtD
Rifabutin—Insomnia—Doxorubicin—hematologic cancer	1.69e-05	0.000129	CcSEcCtD
Rifabutin—Paraesthesia—Doxorubicin—hematologic cancer	1.68e-05	0.000129	CcSEcCtD
Rifabutin—Dyspnoea—Doxorubicin—hematologic cancer	1.67e-05	0.000128	CcSEcCtD
Rifabutin—Feeling abnormal—Epirubicin—hematologic cancer	1.66e-05	0.000127	CcSEcCtD
Rifabutin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.65e-05	0.000127	CcSEcCtD
Rifabutin—Dyspepsia—Doxorubicin—hematologic cancer	1.65e-05	0.000126	CcSEcCtD
Rifabutin—Vomiting—Prednisone—hematologic cancer	1.64e-05	0.000126	CcSEcCtD
Rifabutin—Rash—Prednisone—hematologic cancer	1.63e-05	0.000125	CcSEcCtD
Rifabutin—Dermatitis—Prednisone—hematologic cancer	1.63e-05	0.000125	CcSEcCtD
Rifabutin—Decreased appetite—Doxorubicin—hematologic cancer	1.63e-05	0.000124	CcSEcCtD
Rifabutin—Headache—Prednisone—hematologic cancer	1.62e-05	0.000124	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.61e-05	0.000124	CcSEcCtD
Rifabutin—Pain—Doxorubicin—hematologic cancer	1.6e-05	0.000122	CcSEcCtD
Rifabutin—Abdominal pain—Epirubicin—hematologic cancer	1.6e-05	0.000122	CcSEcCtD
Rifabutin—Body temperature increased—Epirubicin—hematologic cancer	1.6e-05	0.000122	CcSEcCtD
Rifabutin—Hypersensitivity—Methotrexate—hematologic cancer	1.59e-05	0.000122	CcSEcCtD
Rifabutin—Asthenia—Methotrexate—hematologic cancer	1.55e-05	0.000119	CcSEcCtD
Rifabutin—Feeling abnormal—Doxorubicin—hematologic cancer	1.54e-05	0.000118	CcSEcCtD
Rifabutin—Nausea—Prednisone—hematologic cancer	1.53e-05	0.000117	CcSEcCtD
Rifabutin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.53e-05	0.000117	CcSEcCtD
Rifabutin—Pruritus—Methotrexate—hematologic cancer	1.53e-05	0.000117	CcSEcCtD
Rifabutin—Hypersensitivity—Epirubicin—hematologic cancer	1.49e-05	0.000114	CcSEcCtD
Rifabutin—Abdominal pain—Doxorubicin—hematologic cancer	1.48e-05	0.000113	CcSEcCtD
Rifabutin—Body temperature increased—Doxorubicin—hematologic cancer	1.48e-05	0.000113	CcSEcCtD
Rifabutin—Diarrhoea—Methotrexate—hematologic cancer	1.48e-05	0.000113	CcSEcCtD
Rifabutin—Asthenia—Epirubicin—hematologic cancer	1.45e-05	0.000111	CcSEcCtD
Rifabutin—Pruritus—Epirubicin—hematologic cancer	1.43e-05	0.000109	CcSEcCtD
Rifabutin—Diarrhoea—Epirubicin—hematologic cancer	1.38e-05	0.000106	CcSEcCtD
Rifabutin—Hypersensitivity—Doxorubicin—hematologic cancer	1.38e-05	0.000105	CcSEcCtD
Rifabutin—Vomiting—Methotrexate—hematologic cancer	1.37e-05	0.000105	CcSEcCtD
Rifabutin—Rash—Methotrexate—hematologic cancer	1.36e-05	0.000104	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—hematologic cancer	1.36e-05	0.000104	CcSEcCtD
Rifabutin—Headache—Methotrexate—hematologic cancer	1.35e-05	0.000104	CcSEcCtD
Rifabutin—Asthenia—Doxorubicin—hematologic cancer	1.34e-05	0.000103	CcSEcCtD
Rifabutin—Pruritus—Doxorubicin—hematologic cancer	1.32e-05	0.000101	CcSEcCtD
Rifabutin—Vomiting—Epirubicin—hematologic cancer	1.28e-05	9.84e-05	CcSEcCtD
Rifabutin—Nausea—Methotrexate—hematologic cancer	1.28e-05	9.82e-05	CcSEcCtD
Rifabutin—Diarrhoea—Doxorubicin—hematologic cancer	1.28e-05	9.79e-05	CcSEcCtD
Rifabutin—Rash—Epirubicin—hematologic cancer	1.27e-05	9.75e-05	CcSEcCtD
Rifabutin—Dermatitis—Epirubicin—hematologic cancer	1.27e-05	9.75e-05	CcSEcCtD
Rifabutin—Headache—Epirubicin—hematologic cancer	1.27e-05	9.69e-05	CcSEcCtD
Rifabutin—Nausea—Epirubicin—hematologic cancer	1.2e-05	9.19e-05	CcSEcCtD
Rifabutin—Vomiting—Doxorubicin—hematologic cancer	1.19e-05	9.1e-05	CcSEcCtD
Rifabutin—Rash—Doxorubicin—hematologic cancer	1.18e-05	9.03e-05	CcSEcCtD
Rifabutin—Dermatitis—Doxorubicin—hematologic cancer	1.18e-05	9.02e-05	CcSEcCtD
Rifabutin—Headache—Doxorubicin—hematologic cancer	1.17e-05	8.97e-05	CcSEcCtD
Rifabutin—Nausea—Doxorubicin—hematologic cancer	1.11e-05	8.5e-05	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—FGF1—hematologic cancer	6.19e-06	6.1e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6R—hematologic cancer	6.16e-06	6.07e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CREBBP—hematologic cancer	6.16e-06	6.06e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—B3GAT1—hematologic cancer	6.14e-06	6.05e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ASNS—hematologic cancer	6.14e-06	6.05e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—DCK—hematologic cancer	6.14e-06	6.05e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FOXO1—hematologic cancer	6.1e-06	6.01e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDGFRB—hematologic cancer	6.09e-06	6e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—FGF2—hematologic cancer	6.05e-06	5.96e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—hematologic cancer	6.04e-06	5.95e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	6e-06	5.91e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDGFRA—hematologic cancer	6e-06	5.91e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PRKCG—hematologic cancer	5.98e-06	5.89e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JAK1—hematologic cancer	5.98e-06	5.89e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3R1—hematologic cancer	5.97e-06	5.88e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PHYH—hematologic cancer	5.93e-06	5.84e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GMPS—hematologic cancer	5.93e-06	5.84e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FTCD—hematologic cancer	5.93e-06	5.84e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAP2K1—hematologic cancer	5.88e-06	5.79e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—hematologic cancer	5.85e-06	5.76e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CD—hematologic cancer	5.84e-06	5.75e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HDC—hematologic cancer	5.82e-06	5.73e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—JAK2—hematologic cancer	5.8e-06	5.71e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—hematologic cancer	5.78e-06	5.69e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CA—hematologic cancer	5.77e-06	5.68e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BCL2—hematologic cancer	5.75e-06	5.66e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNG—hematologic cancer	5.69e-06	5.61e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MDM2—hematologic cancer	5.66e-06	5.58e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FGF2—hematologic cancer	5.59e-06	5.5e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2RA—hematologic cancer	5.58e-06	5.5e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CG—hematologic cancer	5.56e-06	5.48e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TERT—hematologic cancer	5.52e-06	5.43e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3R1—hematologic cancer	5.51e-06	5.43e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CB—hematologic cancer	5.51e-06	5.43e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MTOR—hematologic cancer	5.51e-06	5.43e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD4—hematologic cancer	5.5e-06	5.42e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	5.43e-06	5.34e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SMPD3—hematologic cancer	5.42e-06	5.34e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDGFB—hematologic cancer	5.39e-06	5.3e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—JAK2—hematologic cancer	5.36e-06	5.28e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—hematologic cancer	5.34e-06	5.25e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—AKT1—hematologic cancer	5.33e-06	5.25e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CDA—hematologic cancer	5.32e-06	5.24e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TSC2—hematologic cancer	5.26e-06	5.18e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MDM2—hematologic cancer	5.23e-06	5.15e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1B—hematologic cancer	5.17e-06	5.09e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CREBBP—hematologic cancer	5.16e-06	5.08e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PC—hematologic cancer	5.12e-06	5.05e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—hematologic cancer	5.11e-06	5.03e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CB—hematologic cancer	5.09e-06	5.01e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MTOR—hematologic cancer	5.09e-06	5.01e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL1B—hematologic cancer	5.08e-06	5e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD4—hematologic cancer	5.08e-06	5e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGFR3—hematologic cancer	5.06e-06	4.99e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2—hematologic cancer	5.06e-06	4.98e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK14—hematologic cancer	5.01e-06	4.94e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GBA—hematologic cancer	4.95e-06	4.87e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC35B2—hematologic cancer	4.95e-06	4.87e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—JUN—hematologic cancer	4.92e-06	4.85e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ESR1—hematologic cancer	4.92e-06	4.84e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CD—hematologic cancer	4.89e-06	4.81e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FN1—hematologic cancer	4.86e-06	4.78e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALB—hematologic cancer	4.83e-06	4.75e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—BAD—hematologic cancer	4.8e-06	4.73e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NFKBIA—hematologic cancer	4.8e-06	4.73e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1B—hematologic cancer	4.77e-06	4.7e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1A—hematologic cancer	4.77e-06	4.7e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTEN—hematologic cancer	4.76e-06	4.69e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH1—hematologic cancer	4.75e-06	4.68e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ASNS—hematologic cancer	4.74e-06	4.67e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—B3GAT1—hematologic cancer	4.74e-06	4.67e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—DCK—hematologic cancer	4.74e-06	4.67e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—hematologic cancer	4.71e-06	4.64e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK8—hematologic cancer	4.66e-06	4.59e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CD80—hematologic cancer	4.66e-06	4.59e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CG—hematologic cancer	4.65e-06	4.58e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KIT—hematologic cancer	4.65e-06	4.58e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3R1—hematologic cancer	4.62e-06	4.55e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTPN11—hematologic cancer	4.57e-06	4.5e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EP300—hematologic cancer	4.54e-06	4.47e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTAP—hematologic cancer	4.53e-06	4.46e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HDC—hematologic cancer	4.49e-06	4.42e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CREB1—hematologic cancer	4.43e-06	4.36e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—SRC—hematologic cancer	4.42e-06	4.35e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1A—hematologic cancer	4.41e-06	4.34e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTEN—hematologic cancer	4.4e-06	4.33e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—BRAF—hematologic cancer	4.37e-06	4.3e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL2—hematologic cancer	4.33e-06	4.26e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6R—hematologic cancer	4.32e-06	4.25e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CREBBP—hematologic cancer	4.31e-06	4.25e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CB—hematologic cancer	4.26e-06	4.2e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—hematologic cancer	4.26e-06	4.19e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NRAS—hematologic cancer	4.25e-06	4.18e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EP300—hematologic cancer	4.19e-06	4.13e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAP2K1—hematologic cancer	4.11e-06	4.05e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CDA—hematologic cancer	4.11e-06	4.05e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CD—hematologic cancer	4.09e-06	4.03e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SRC—hematologic cancer	4.08e-06	4.02e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK3—hematologic cancer	4.07e-06	4.01e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FHL2—hematologic cancer	4.03e-06	3.97e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AGRN—hematologic cancer	3.96e-06	3.9e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PC—hematologic cancer	3.95e-06	3.89e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—hematologic cancer	3.93e-06	3.87e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NRAS—hematologic cancer	3.92e-06	3.86e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGF2—hematologic cancer	3.91e-06	3.85e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3R1—hematologic cancer	3.86e-06	3.8e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GBA—hematologic cancer	3.82e-06	3.76e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC35B2—hematologic cancer	3.82e-06	3.76e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK3—hematologic cancer	3.76e-06	3.7e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JAK2—hematologic cancer	3.75e-06	3.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—IDH2—hematologic cancer	3.75e-06	3.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMMR—hematologic cancer	3.75e-06	3.69e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTEN—hematologic cancer	3.68e-06	3.63e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MDM2—hematologic cancer	3.66e-06	3.61e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—hematologic cancer	3.66e-06	3.6e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—hematologic cancer	3.65e-06	3.6e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFB1—hematologic cancer	3.64e-06	3.59e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MTOR—hematologic cancer	3.56e-06	3.51e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CB—hematologic cancer	3.56e-06	3.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.54e-06	3.48e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ARNTL—hematologic cancer	3.53e-06	3.47e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—EP300—hematologic cancer	3.51e-06	3.46e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTAP—hematologic cancer	3.49e-06	3.44e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA9—hematologic cancer	3.43e-06	3.38e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ACP5—hematologic cancer	3.43e-06	3.38e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NCOR2—hematologic cancer	3.39e-06	3.33e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—hematologic cancer	3.38e-06	3.32e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—hematologic cancer	3.36e-06	3.31e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1B—hematologic cancer	3.34e-06	3.29e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP3—hematologic cancer	3.28e-06	3.23e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—hematologic cancer	3.27e-06	3.22e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—IDH1—hematologic cancer	3.23e-06	3.18e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—hematologic cancer	3.19e-06	3.14e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCC3—hematologic cancer	3.19e-06	3.14e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TXN—hematologic cancer	3.19e-06	3.14e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTO1—hematologic cancer	3.19e-06	3.14e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JUN—hematologic cancer	3.18e-06	3.13e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SPHK1—hematologic cancer	3.12e-06	3.07e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FHL2—hematologic cancer	3.11e-06	3.07e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—hematologic cancer	3.11e-06	3.06e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—hematologic cancer	3.1e-06	3.05e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1A—hematologic cancer	3.09e-06	3.04e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTEN—hematologic cancer	3.08e-06	3.03e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AGRN—hematologic cancer	3.05e-06	3.01e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK8—hematologic cancer	3.01e-06	2.97e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—UGT1A1—hematologic cancer	3e-06	2.95e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—hematologic cancer	2.97e-06	2.93e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EP300—hematologic cancer	2.94e-06	2.89e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CRABP1—hematologic cancer	2.92e-06	2.87e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC22A1—hematologic cancer	2.92e-06	2.87e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—IDH2—hematologic cancer	2.89e-06	2.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMMR—hematologic cancer	2.89e-06	2.85e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—hematologic cancer	2.87e-06	2.83e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SRC—hematologic cancer	2.85e-06	2.81e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALOX5—hematologic cancer	2.84e-06	2.8e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—hematologic cancer	2.78e-06	2.74e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—hematologic cancer	2.75e-06	2.71e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NUP98—hematologic cancer	2.75e-06	2.71e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NRAS—hematologic cancer	2.75e-06	2.7e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—hematologic cancer	2.75e-06	2.7e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—hematologic cancer	2.74e-06	2.7e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.72e-06	2.68e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ADCY7—hematologic cancer	2.67e-06	2.63e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NCOA3—hematologic cancer	2.67e-06	2.63e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NUP214—hematologic cancer	2.65e-06	2.61e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ACP5—hematologic cancer	2.65e-06	2.61e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA9—hematologic cancer	2.65e-06	2.61e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK3—hematologic cancer	2.63e-06	2.59e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.63e-06	2.59e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.61e-06	2.57e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCG2—hematologic cancer	2.6e-06	2.56e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTR—hematologic cancer	2.6e-06	2.56e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—hematologic cancer	2.6e-06	2.56e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—hematologic cancer	2.56e-06	2.52e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFB1—hematologic cancer	2.55e-06	2.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ENO2—hematologic cancer	2.55e-06	2.51e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—hematologic cancer	2.53e-06	2.5e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—IDH1—hematologic cancer	2.49e-06	2.45e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.47e-06	2.44e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.46e-06	2.42e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TXN—hematologic cancer	2.46e-06	2.42e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.46e-06	2.42e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.43e-06	2.4e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SDC1—hematologic cancer	2.42e-06	2.38e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.41e-06	2.37e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—hematologic cancer	2.36e-06	2.33e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.31e-06	2.28e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.31e-06	2.27e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.28e-06	2.24e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.25e-06	2.22e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.25e-06	2.22e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.19e-06	2.16e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.18e-06	2.15e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—hematologic cancer	2.17e-06	2.14e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NUP98—hematologic cancer	2.12e-06	2.09e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—hematologic cancer	2.12e-06	2.09e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—hematologic cancer	2.1e-06	2.07e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.06e-06	2.03e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.06e-06	2.03e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NQO1—hematologic cancer	2.05e-06	2.02e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CD44—hematologic cancer	2.05e-06	2.02e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NUP214—hematologic cancer	2.05e-06	2.02e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.01e-06	1.98e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—hematologic cancer	2.01e-06	1.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTR—hematologic cancer	2.01e-06	1.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.01e-06	1.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ENO2—hematologic cancer	1.97e-06	1.94e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYCS—hematologic cancer	1.94e-06	1.92e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.93e-06	1.9e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—hematologic cancer	1.92e-06	1.89e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.91e-06	1.88e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SDC1—hematologic cancer	1.87e-06	1.84e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—hematologic cancer	1.77e-06	1.75e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.74e-06	1.71e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.71e-06	1.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.66e-06	1.63e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.62e-06	1.6e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NQO1—hematologic cancer	1.59e-06	1.56e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CD44—hematologic cancer	1.59e-06	1.56e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.57e-06	1.55e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.57e-06	1.55e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYCS—hematologic cancer	1.5e-06	1.48e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.49e-06	1.47e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.39e-06	1.37e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.32e-06	1.3e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.25e-06	1.23e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.23e-06	1.21e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.22e-06	1.2e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.22e-06	1.2e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.17e-06	1.15e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.08e-06	1.07e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.07e-06	1.06e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.03e-06	1.01e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALB—hematologic cancer	1.01e-06	1e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3R1—hematologic cancer	9.71e-07	9.56e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	9.03e-07	8.89e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CB—hematologic cancer	8.96e-07	8.83e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CREBBP—hematologic cancer	8.37e-07	8.24e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	7.93e-07	7.81e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALB—hematologic cancer	7.83e-07	7.71e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTEN—hematologic cancer	7.74e-07	7.63e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	7.49e-07	7.38e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—EP300—hematologic cancer	7.38e-07	7.27e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	6.92e-07	6.81e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTEN—hematologic cancer	5.98e-07	5.89e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—EP300—hematologic cancer	5.7e-07	5.61e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—hematologic cancer	5.46e-07	5.38e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—hematologic cancer	4.46e-07	4.4e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.22e-07	4.15e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—hematologic cancer	3.44e-07	3.39e-06	CbGpPWpGaD
